Funding for this research was provided by:
National Institutes of Health (5T32CA009695-27)
Bristol-Myers Squibb
Novocure
Article History
Received: 15 April 2021
Accepted: 31 July 2021
First Online: 19 August 2021
Declarations
:
: GL is a consultant for Medtronic, a speaker for DePuy Synthes/Johnson & Johnson, and owns stock in Abbott, Biogen, BioMarin Pharmaceutical, Inc., Bristol Myers Squibb, Exact Sciences, GlaxoSmithKline, Gilead Sciences, Inc., Merck & Co., Pfizer, and Stryker.
: All authors.